Color, the pioneering health technology company dedicated to making population-scale healthcare accessible and effective, has successfully raised an impressive $41 million in its latest funding round. This capital boost will bolster Color’s innovative approach to preventive health and disease management, focusing primarily on cancer early detection, screening, and care management. By partnering with employers, labor unions, national health initiatives, and public health institutions, Color is committed to transforming healthcare delivery into a convenient and cost-effective service that seamlessly integrates into the fabric of everyday life.
The funding will be instrumental in expanding Color's partnerships, particularly with the American Cancer Society, to enhance its cancer prevention and screening program. This initiative has already proven to significantly impact the lives of employees and union members, leading to a reduction in cancer-related costs while fostering a proactive healthcare culture. With this investment, Color aims to refine its robust clinical capabilities, including lab networks, medical supply chains, and a dedicated pool of providers, ensuring that care is activated wherever life happens—whether at work, in the community, at local churches, or in the comfort of people’s homes.
At Color, the mission is clear: to look for cancer, while simultaneously looking out for people. This new round of funding not only reinforces Color’s commitment to transforming healthcare access but also reflects the growing recognition of the critical role preventive health plays in fostering healthier communities. As Color continues to innovate and expand its reach, it remains steadfast in its objective to deliver effective health solutions that empower individuals to take charge of their well-being.
